PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.
about
Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathwayTSG101, a tumor susceptibility gene, bidirectionally modulates cell invasion through regulating MMP-9 mRNA expression.Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53.Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation.HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.Metastasis suppressors: functional pathways.
P2860
Q33517129-5E512A71-CEB5-47FA-81E3-1B25C1133CBCQ33517958-399BFACB-F61E-41C2-A5CC-1C3E87ACE885Q35853421-CA8AFF9F-DE03-4F1F-9895-D97AB1FDDC27Q36232928-1A842774-75AD-4F38-B3B1-50ED98373C9CQ39291875-48763770-6CF4-485B-A67E-4B0D25359323Q39618849-AFD438B1-CDC4-457B-9716-24DFB660FAD8Q40548675-552CACE6-E2A8-4EC4-98AC-4EEC2EF9AE0EQ43848237-CE995BF7-0990-45FC-BE89-D18EE1027DF8Q47716769-61DD8E18-FA9F-4AF0-A242-C383E3ABD91A
P2860
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
PD 098059, an inhibitor of ERK ...... neck squamous cell carcinoma.
@ast
PD 098059, an inhibitor of ERK ...... neck squamous cell carcinoma.
@en
type
label
PD 098059, an inhibitor of ERK ...... neck squamous cell carcinoma.
@ast
PD 098059, an inhibitor of ERK ...... neck squamous cell carcinoma.
@en
prefLabel
PD 098059, an inhibitor of ERK ...... neck squamous cell carcinoma.
@ast
PD 098059, an inhibitor of ERK ...... neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1476
PD 098059, an inhibitor of ERK ...... neck squamous cell carcinoma.
@en
P2093
A J Nemechek
B W O'Malley
C M Flaitz
H Goepfert
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690537
P407
P577
1999-07-01T00:00:00Z
P5875
P6179
1035771240